company background image
HPC logo

Hydration Pharmaceuticals ASX:HPC Stock Report

Last Price

AU$0.017

Market Cap

AU$5.2m

7D

-5.6%

1Y

-32.0%

Updated

21 Dec, 2024

Data

Company Financials

The Hydration Pharmaceuticals Company Limited

ASX:HPC Stock Report

Market Cap: AU$5.2m

HPC Stock Overview

The Hydration Pharmaceuticals Company Limited markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, the Unites States, and Canada. More details

HPC fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

The Hydration Pharmaceuticals Company Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Hydration Pharmaceuticals
Historical stock prices
Current Share PriceAU$0.017
52 Week HighAU$0.035
52 Week LowAU$0.009
Beta1.28
1 Month Change0%
3 Month Changen/a
1 Year Change-32.00%
3 Year Change-94.43%
5 Year Changen/a
Change since IPO-95.21%

Recent News & Updates

Take Care Before Jumping Onto The Hydration Pharmaceuticals Company Limited (ASX:HPC) Even Though It's 31% Cheaper

Jun 25
Take Care Before Jumping Onto The Hydration Pharmaceuticals Company Limited (ASX:HPC) Even Though It's 31% Cheaper

Sentiment Still Eluding The Hydration Pharmaceuticals Company Limited (ASX:HPC)

May 02
Sentiment Still Eluding The Hydration Pharmaceuticals Company Limited (ASX:HPC)

Recent updates

Take Care Before Jumping Onto The Hydration Pharmaceuticals Company Limited (ASX:HPC) Even Though It's 31% Cheaper

Jun 25
Take Care Before Jumping Onto The Hydration Pharmaceuticals Company Limited (ASX:HPC) Even Though It's 31% Cheaper

Sentiment Still Eluding The Hydration Pharmaceuticals Company Limited (ASX:HPC)

May 02
Sentiment Still Eluding The Hydration Pharmaceuticals Company Limited (ASX:HPC)

Is Hydration Pharmaceuticals (ASX:HPC) In A Good Position To Invest In Growth?

Mar 15
Is Hydration Pharmaceuticals (ASX:HPC) In A Good Position To Invest In Growth?

Shareholder Returns

HPCAU Personal ProductsAU Market
7D-5.6%1.6%-2.7%
1Y-32.0%31.4%6.5%

Return vs Industry: HPC underperformed the Australian Personal Products industry which returned 31.4% over the past year.

Return vs Market: HPC underperformed the Australian Market which returned 6.5% over the past year.

Price Volatility

Is HPC's price volatile compared to industry and market?
HPC volatility
HPC Average Weekly Movement62.0%
Personal Products Industry Average Movement6.0%
Market Average Movement8.0%
10% most volatile stocks in AU Market16.8%
10% least volatile stocks in AU Market3.1%

Stable Share Price: HPC's share price has been volatile over the past 3 months compared to the Australian market.

Volatility Over Time: Insufficient data to determine HPC's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001n/aOliver Bakerwww.hydralyte.com

The Hydration Pharmaceuticals Company Limited markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, the Unites States, and Canada. It sells its products under the Hydralyte brand name through retail stores and e-commerce channels. The Hydration Pharmaceuticals Company Limited was founded in 2001 and is headquartered in Melbourne, Australia.

The Hydration Pharmaceuticals Company Limited Fundamentals Summary

How do Hydration Pharmaceuticals's earnings and revenue compare to its market cap?
HPC fundamental statistics
Market capAU$5.18m
Earnings (TTM)-AU$12.28m
Revenue (TTM)AU$15.51m

0.3x

P/S Ratio

-0.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HPC income statement (TTM)
RevenueUS$9.70m
Cost of RevenueUS$4.27m
Gross ProfitUS$5.43m
Other ExpensesUS$13.12m
Earnings-US$7.68m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.025
Gross Margin56.00%
Net Profit Margin-79.18%
Debt/Equity Ratio-170.3%

How did HPC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 00:30
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

The Hydration Pharmaceuticals Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution